OCUL

Ocular Therapeutix INC

-$576.7M

Net Activity

Institutions Holding

272

Popularity Rank

#2193

Avg Weight

0.42%

Total Value

$1.8B

Ownership Trend

272 institutions currently hold OCUL, with 176 net buyers and 114 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

114

Net Buying Institutions

176

Key Holders

View all 272 holding institutions

Quarterly Activity

Recent Activity

+$1.5B

Total Buy Value

$724.3M

Total Sell Value

New buy70
Trim63
Add106
Sold out51

176

Net Buyers

114

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$123K

Total Est. Value

15K shares

Planned Shares

Last Filed 2026-06-03
FilerFiling DateEst. Value
Waheed Nadia2026-06-03$123K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding OCULAR THERAPEUTIX INC (OCUL)?
Major stakeholders currently include FMR LLC ($276.6M), Deep Track Capital, LP ($166.7M), BlackRock, Inc. ($136.6M). Based on the latest 13F filings, there are a total of 272 tracked investment funds and institutions maintaining positions in OCUL.
What is the overall institutional sentiment toward OCUL recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $576.7M, driven by 176 managers accumulating shares while 114 reduced their exposure.
Which institutions have been selling or reducing their OCUL positions?
In the latest period, 63 funds trimmed their holdings, and 51 managers completely exited their positions. The aggregate reported sell value was $724.3M.
Are there any notable investors adding OCUL to their portfolios?
Yes, buying activity remains notable. 70 institutions opened new positions in {ticker}, and 106 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.5B.

Related Stocks